Intellectual Property and Emergencies: Policy for Medicines and Vaccines
Submit questions to [email protected] or on Twitter with #AskAEIHealth. In anticipation of threats to public health such as pandemics, infectious disease outbreaks, or biological warfare, the US government may exercise several approaches to ensure a sustained supply of needed medicines. This may include advanced purchase commitments, priority review or other regulatory incentives, or taking intellectual […]
August 30, 2023
Register